1Hammar A,Lund A,Hugdahl K.Long-lasting cognitive impairment in unipolar major depression:a 6-month follow-up study.Psychiatry Res,2003,118:189–196.
2Allain H,Lieury A,Brunet-Bourgin F,et al.Antidepressants and cognition:comparative effects of moclobemide,viloxazine and maprotiline.Psychopharmacology (Berl),1992,106:56-61.
3van Laar MW,Volkerts ER,Verbaten MN,et al.Differential effects of amitriptyline,nefazodone and paroxetine on performance and brain indices of visual selective attention and working memory.Psychopharmacology (Berl),2002,162:351-363.
4Fairweather DB,Ashford J,Hindmarch I.Effects of fluvoxamine and dothiepin on psychomotor abilities in healthy volunteers.Pharmacol Biochem Behav,1996,53:265-269.
5Trick L,Stanley N,Rigney U,et al.A double-blind,randomized,26-week study comparing the cognitive and psychomotor effects and efficacy of 75 mg (37.5 mg b.i.d.) venlafaxine and 75 mg (25 mg mane,50 mg nocte) dothiepin in elderly patients with moderate major depression being treated in general practice.J Psychopharmacol,2004,18:205-214.
6Paul MA,Gray GW,Love RJ,et al.SSRI effects on pyschomotor performance:assessment of citalopram and escitalopram on normal subjects.Aviat Space Environ Med,2007,78:693-697.
7Siepmann M,Grossmann J,Mück-Weymann M,et al.Effects of sertraline on autonomic and cognitive functions in healthy volunteers.Psychopharmacology (Berl),2003,168:293-298.
8Hasbroucq T,Rihet P,Blin O,Possamai CA.Serotonin and human information processing:fluvoxamine can improve reaction time performance.Neurosci Lett,1997,229:204-208.
9Schmitt JA,Kruizinga MJ,Riedel WJ.Non-serotonergic pharmacological profiles and associated cognitive effects of serotonin reuptake inhibitors.J Psychopharmacol,2001,15:173-179.
10Herrera-Guzmán I,Gudayol-Ferré E,Herrera-Guzmán D,et al.Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder.J Psychiatr Res,2009,43:855-863.
